CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements

Pharmacogenomics, Ahead of Print.
Source: Future Medicine: Pharmacogenomics - Category: Genetics & Stem Cells Authors: Source Type: research
More News: Coumadin | Genetics | Warfarin